Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Cyclophosphamide for multiple sclerosis.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Exercise and quality of life in women with multiple sclerosis.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Fatigue in multiple sclerosis - A brief review.
Central nervous system lymphoma associated with natalizumab.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
The safety of exercise training in multiple sclerosis: A systematic review.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Pages
« first
‹ previous
…
164
165
166
167
168
169
170
171
172
…
next ›
last »